Breast Cancer Imaging and Therapy
In Canada, survival from breast cancer has steadily increased since 1989, and breast cancer mortality has decreased by 48%. While 82% of women with breast cancer are diagnosed at stage 1 or 2, there are still 18% who present at a late stage and 25% who develop metastatic disease. Improved survival h...
Saved in:
Other Authors: | |
---|---|
Format: | Electronic Book Chapter |
Language: | English |
Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
Subjects: | |
Online Access: | DOAB: download the publication DOAB: description of the publication |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000naaaa2200000uu 4500 | ||
---|---|---|---|
001 | doab_20_500_12854_101387 | ||
005 | 20230714 | ||
003 | oapen | ||
006 | m o d | ||
007 | cr|mn|---annan | ||
008 | 20230714s2023 xx |||||o ||| 0|eng d | ||
020 | |a books978-3-0365-7931-3 | ||
020 | |a 9783036579306 | ||
020 | |a 9783036579313 | ||
040 | |a oapen |c oapen | ||
024 | 7 | |a 10.3390/books978-3-0365-7931-3 |c doi | |
041 | 0 | |a eng | |
042 | |a dc | ||
072 | 7 | |a M |2 bicssc | |
072 | 7 | |a MJCL |2 bicssc | |
100 | 1 | |a Seely, Jean |4 edt | |
700 | 1 | |a Seely, Jean |4 oth | |
245 | 1 | 0 | |a Breast Cancer Imaging and Therapy |
260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2023 | ||
300 | |a 1 electronic resource (228 p.) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
520 | |a In Canada, survival from breast cancer has steadily increased since 1989, and breast cancer mortality has decreased by 48%. While 82% of women with breast cancer are diagnosed at stage 1 or 2, there are still 18% who present at a late stage and 25% who develop metastatic disease. Improved survival has been achieved through early diagnosis of breast cancer with screening, allowing for more effective and targeted treatments. This reprint summarizes the latest evidence on the early detection of breast cancer and highlights areas where this may be improved. | ||
540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
546 | |a English | ||
650 | 7 | |a Medicine |2 bicssc | |
650 | 7 | |a Oncology |2 bicssc | |
653 | |a contrast-enhanced spectral mammography | ||
653 | |a breast cancer | ||
653 | |a neoadjuvant chemotherapy | ||
653 | |a complete response | ||
653 | |a response evaluation criteria in solid tumors | ||
653 | |a contrast-enhanced mammography | ||
653 | |a magnetic resonance imaging | ||
653 | |a image enhancement | ||
653 | |a contrast media | ||
653 | |a radiomics | ||
653 | |a artificial intelligence | ||
653 | |a breast | ||
653 | |a cancer | ||
653 | |a screening | ||
653 | |a dense | ||
653 | |a patient advocacy | ||
653 | |a breast density | ||
653 | |a breast density notification | ||
653 | |a Canada | ||
653 | |a mammography | ||
653 | |a breast ultrasound | ||
653 | |a breast cancer screening | ||
653 | |a interval cancer | ||
653 | |a mortality reduction | ||
653 | |a breast MRI | ||
653 | |a digital breast tomosynthesis | ||
653 | |a molecular breast imaging | ||
653 | |a overdetection | ||
653 | |a Canadian National Breast Screening Study | ||
653 | |a overdiagnosis | ||
653 | |a overtreatment | ||
653 | |a microsimulation | ||
653 | |a mammographic screening | ||
653 | |a randomization | ||
653 | |a expertise | ||
653 | |a guidelines | ||
653 | |a evidenc | ||
653 | |a epistemic trespassing | ||
653 | |a evidence-based medicine | ||
653 | |a risk factors | ||
653 | |a screening mammography | ||
653 | |a knowledge assessment | ||
653 | |a barriers | ||
653 | |a questionnaire examination | ||
653 | |a DBT | ||
653 | |a ultrasound | ||
653 | |a benign biopsy | ||
653 | |a stage shift | ||
653 | |a registries | ||
653 | |a prevention | ||
653 | |a recommendations | ||
653 | |a clinical practice | ||
653 | |a breast screening | ||
653 | |a high-risk breast screening | ||
653 | |a dense breasts | ||
653 | |a supplemental breast screening | ||
653 | |a cardiovascular disease | ||
653 | |a chemotherapy | ||
653 | |a radiotherapy | ||
653 | |a mortality | ||
653 | |a adjuvant endocrine therapy | ||
653 | |a adherence to treatment | ||
653 | |a side effects | ||
653 | |a tamoxifen | ||
653 | |a aromatase inhibitors | ||
653 | |a GnRH agonist | ||
653 | |a questionnaire | ||
653 | |a n/a | ||
856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/7483 |7 0 |z DOAB: download the publication |
856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/101387 |7 0 |z DOAB: description of the publication |